Brief: Sprint Bioscience Q4 Operating Loss Narrows To SEK 4.9 Million

Sprint Bioscience AB

12/02/2025 06:39

Feb 12 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * Q4 NET SALES SEK 16.3 MILLION VERSUS SEK 10.9 MILLION YEAR
AGO
    * Q4 OPERATING LOSS SEK 4.9 MILLION VERSUS LOSS SEK 5.1
MILLION
YEAR AGO
    * PROPOSES THAT NO DIVIDEND BE PAID FOR FINANCIAL YEAR 2024

Source text:  ID:nMFN8pyYPS 
Further company coverage:  SPRINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))